Co-Diagnostics Overview
DCF fair value estimate for Co-Diagnostics: $7.9.
Get informed when a big investor buys or sells
+ Follow$7.86
Undervalued by 431.1% based on the discounted cash flow analysis.
As of the most recent data, CODX shows a DCF fair value of $7.9. Scroll down for historical charts and peer comparison views.
Co-Diagnostics's DCF reading of $7.9 (431.1% undervalued) is a model output, not a certainty. Small changes in long-term growth or the discount rate can move fair value a lot. Treat the number as a structured starting point, then verify whether Co-Diagnostics's recent cash-flow history supports the assumptions.
Besides this discounted cash flow page, Stockcircle has Co-Diagnostics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect DCF fair value (currently $7.9) with ownership activity and broader fundamentals.
Co-Diagnostics's DCF fair value is $7.9; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
